It has been suggested that increased blood pressure (BP) variability is a risk factor for cardiovascular outcomes. Although several variability indices have been suggested as a phenotype that represents the frailty of hemodynamic control, orthostatic change in BP is one of the most investigated variability indices. An excessive BP drop after postural change, namely, orthostatic hypotension, was associated with cardiovascular diseases, 1-3 including stroke 4 and mortality, 5, 6 not only in the elderly 3,5 but also in middle-aged 1,2,4,6 populations.
Original article
It has been suggested that increased blood pressure (BP) variability is a risk factor for cardiovascular outcomes. Although several variability indices have been suggested as a phenotype that represents the frailty of hemodynamic control, orthostatic change in BP is one of the most investigated variability indices. An excessive BP drop after postural change, namely, orthostatic hypotension, was associated with cardiovascular diseases, [1] [2] [3] including stroke 4 and mortality, 5, 6 not only in the elderly 3, 5 but also in middle-aged 1, 2, 4, 6 populations.
Another variability index recently given attention is dayto-day variability, usually calculated by multiday home measures of morning BP values. Increased day-to-day variability has also been associated with cardiovascular disease [7] [8] [9] and mortality 7, 8, 10 in various populations, and the prognostic significance was supported by a recent largescale meta-analysis. 11 Home BP is more feasibly measurable than ambulatory BP and more repeatedly measurable than office BP, which provides more information about short-and long-term BP variation, respectively. Day-to-day variability in home BP may therefore be a superior index over other variability indices and may provide more accurate information on the prognosis of cardiovascular outcomes likewise a better prediction of cardiovascular diseases by self-measured home BP than office BP. 12, 13 However, factors involved in home BP variability are largely unknown, although several studies suggest plasma levels of N-terminal pro-B-type natriuretic peptide as a determinant for day-to-day home BP variability, 14 as well as visit-to-visit office BP variability. 15 We previously reported that changes in orthostatic BP were associated with masked and white-coat phenomenon, 16 suggesting a possible relationship between changes in BP by orthostatic stimuli and day-to-day home BP variability.
Here, we analyzed a dataset of the Nagahama Prospective Cohort for Comprehensive Human Bioscience Study (the Nagahama Study), a general population-based longitudinal cohort study in Japan, to clarify possible intercorrelations between day-to-day BP variability and orthostatic BP change. As atherosclerosis of large artery was suggested as one of the pathological factors for both orthostatic BP dysregulation 17 and large day-to-day 18, 19 and 24 hours 20, 21 BP variability, we also investigated the association of carotid intima-media thickness (IMT), an established marker of atherosclerosis, as a shared factor between day-to-day and orthostatic BP variations. We further investigated the association of B-type natriuretic peptide (BNP), a previously suggested factor for day-to-day BP variability, 14, 15 to confirm its involvement. Results may be an important information to understand the pathophysiology of day-to-day BP variability and to interpret the results of epidemiological studies for the BP variability.
METHODS

Study participants
We analyzed the second visit dataset of the Nagahama Study. Participants in the Nagahama Study were recruited between 2008 and 2010 from the general population of Nagahama, a rural city of 125,000 inhabitants located in central Japan. Community residents aged between 30 and 74 years and who were living independently without physical impairment or dysfunction were eligible. Of the 9,804 participants, 14 withdrew consent, and 26 were excluded because of genetic analysis demonstrating a different ethnic background. Among the remaining baseline population (n = 9,764), 8,289 individuals participated in the second health survey performed at 5 years after baseline evaluations. By recruiting an additional 1,561 participants who met the study criteria, the second visit dataset of the Nagahama Study consisted of 9,850 participants.
A total of 6,465 participants were ultimately included in the analysis after excluding individuals according to the following criteria: (i) pregnant women (n = 9), (ii) pacemaker implantation (n = 12), (iii) hemodialysis therapy (n = 5), (iv) severe renal functional decline (estimated glomerular filtration rate <30 ml/min/1.73 m 2 or urinary albumin ≥300 mg/ day; n = 459), (v) incomplete measurement of orthostatic BP change (n = 197), (vi) no measurement or insufficient measurement of home BP (n = 2,684), (vii) suspected shift workers (n = 17), and (viii) lack of clinical values required for the present study (n = 2).
All study procedures were approved by the ethics committee of Kyoto University Graduate School of Medicine and by the Nagahama Municipal Review Board. Written informed consent was obtained from all participants.
Measurement of home BP
Home BP monitoring was an optional examination made upon request. An automated cuff-oscillometric device (HEM-7080IC; Omron Healthcare, Kyoto, Japan) was provided to participants to measure BP at home. Participants were required to measure morning and evening BP for 7 days using the following procedures: for morning BP, measure BP by themselves in a seated position within 1 hour of waking, before taking antihypertensive drugs and before breakfast, after urination, and after a few minutes of rest in a seated position; (ii) for evening BP, measure BP by themselves in a seated position within 1 hour of going to bed, after urination, and after a few minutes of rest in a seated position. During this period, participants were also required to wear a wristband activity monitor (Actiwatch 2 or Actiwatch Spectrum Plus, Philips Respironics, Murrysville, PA) and write daily in a sleep diary to objectively determine sleep period. Among the recorded BPs, BP values measured within 1 hour after waking and within 1 hour before sleeping were considered as morning and evening BP, respectively. If there were multiple readings in each timeslot, the mean value was calculated as a representative value. A total of 7,261 participants measured home BP for at least 1 day. Among them, those who measured morning BP for >3 days were included in the analysis.
Calculation of home BP variability
Home BP variability was assessed by SD, coefficient of variation (CV), and average real variability (ARV). CV was a percent ratio of SD of the mean. ARV was calculated using the following formula 22 :
where N indicated the number of measurements.
Measurement of office BP and orthostatic BP change
Seated BP was measured using an automated cuff-oscillometric device (HEM-9000AI; Omron Healthcare) after a few minutes rest in a seated position. Measurements were taken twice, and the mean value was used for the analysis. After the measurement, participants were asked to stand without any assistance, and orthostatic BP was remeasured 1 and 3 minutes after standing. Orthostatic changes in BP were calculated as the maximum difference between BPs measured seated and after the postural change. If any 2 orthostatic BP measurements were not successful, individuals were excluded from the analysis.
Carotid hypertrophy
Carotid IMT was measured as an index of atherosclerosis using one of the following devices with a 7.5 MHz probe: Prosound 2 or SSD-3500SV (Aloka, Tokyo, Japan), XARIO SSA-660A (Toshiba Medical Systems Corporation, Tochigi, Japan), or UF-760AG (Fukuda Denshi, Tokyo, Japan). After a few minutes of rest in a supine position, IMT of the far wall was manually (Aloka or Toshiba) or automatically (Fukuda Denshi) measured from B-mode images at 1 cm intervals, proximal to the bulb from the lateral approach. For the analysis, mean IMT was manually calculated from the 3 readings or automatically measured for 272 readings within a 2 cm range.
Basic clinical characteristics
Basic clinical characteristics, including plasma levels of BNP, were obtained at the follow-up investigation. Drinking and smoking habits, medication use, and a history of cardiovascular disease (symptomatic stroke or ischemic heart disease) were determined using a structured, self-administered questionnaire. Alcohol consumption was measured using the Japanese traditional unit of alcohol (Go), where 1 Go = 22 g of ethanol. Hypertension was defined as any or all of systolic BP (SBP) ≥140 mm Hg, diastolic BP ≥90 mm Hg, or taking antihypertensive drugs. Hyperglycemia was defined as any of HbA1c ≥6.5%, fasting plasma glucose ≥126 mg/dl, occasional plasma glucose ≥200 mg/dl, or taking antihyperglycemic drugs. Hyperlipidemia was defined as any or all of low-density lipoprotein cholesterol ≥140 mg/ dl, high-density lipoprotein cholesterol <40 mg/dl, or taking antihyperlipidemic drugs. We did not consider triglyceride level due to including participants at nonfasting condition.
Statistical analysis
Values were mean ± SD or frequency. Group differences in numeric variables were assessed by analysis of variance, and Dunnett's test was used for post hoc analysis. Frequency difference was assessed by chi-squared test. Factors independently associated with BP variability were assessed by linear regression analysis. All statistical analysis was performed using JMP statistical software (JMP Pro ver. 13.2.0; SAS Institute, Cary, NC). A P value of < 0.05 was considered statistically significant.
RESULTS
Clinical characteristics of study participants are summarized in Table 1 . Although mean BP levels at 1 or 3 minutes after standing were like those measured while seated, a substantial number of participants showed orthostatic SBP change >±10 mm Hg (Table 2) . Differences in clinical characteristics among the subgroups divided by the orthostatic SBP changes are shown in Table 2 . Baseline seated SBP was higher in the orthostatic hypotensive participants. Home morning and evening SBPs, frequency of taking antihypertensive drugs, hypertension, and mean carotid IMT showed a U-shaped relationship with the degree of orthostatic SBP change. Figure 1 depicts differences in day-to-day morning SBP variability among the subgroups by postural SBP change. The morning SBP variability was significantly larger in orthostatic hypotensive subgroups regardless of the indices used for the analysis, and the large variability in the orthostatic hypotensive groups was independent of major covariates including office seated SBP and antihypertensive medication (Table 3) . When morning mean SBP was adjusted instead of the office SBP, the association between orthostatic SBP decline and morning BP variability remained statistically significant (CV, orthostatic SBP change ≥−10 mm Hg: β = 0.040, P = 0.002, ≥−20 mm Hg: β = 0.052, P < 0.001; ARV, orthostatic SBP change ≥−10 mm Hg: β = 0.026, P = 0.036, ≥−20 mm Hg: β = 0.037, P = 0.003). Because the frequency of orthostatic hypotension was higher in the older subpopulation (orthostatic SBP change ≥−10 mm Hg: ≥60 years: 23.4%; <60 years: 9.9%), the association was slightly stronger in the subanalysis in older participants (Table 3) . No clear association was observed in the analysis for evening SBP variability (Table 4) . When orthostatic hypertension was considered in the regression analysis, it did not show significant association with morning BP variability (CV, orthostatic SBP change ≥10 mm Hg: β = 0.021, P = 0.096, ≥20 mm Hg: β = −0.005, P = 0.713; ARV, orthostatic SBP change ≥10 mm Hg: β = 0.020, P = 0.104, ≥20 mm Hg: β = 0.008, P = 0.535).
Full results of the regression analyses are shown in Supplementary Tables 1-4 . Carotid IMT was significantly associated with day-to-day morning (ARV: β = 0.052, P = 0.001) and evening (β = 0.065, P < 0.001) SBP variability. Carotid IMT was also significantly associated with orthostatic BP change in a simple comparison (Table 2) , as well as in a regression analysis for absolute value of orthostatic BP change (β = 0.049, P = 0.001) independent of age, sex, body mass index, seated SBP, and use of antihypertensive drugs. In this regression model, orthostatic BP change was transformed as an absolute value because of the U-shaped relationship with carotid IMT (Table 2) .
Alcohol consumption was another factor that was independently associated with evening (ARV: β = 0.093, P < 0.001) but not morning (P = 0.085) SBP variability, although it showed positive association with morning (age, sex, BMI, and antihypertensive medication adjusted β = 0.137, P < 0.001) but not evening (β = −0.006, P = 0.616) SBP level.
Plasma levels of BNP did not show significant association with morning and evening SBP variability (Supplementary  Tables 1-4) .
DISCUSSION
In this cross-sectional analysis in a general population, orthostatic hypotensive individuals were more likely to have large day-to-day morning BP variability. This association was independent of major confounding factors, including baseline BP levels. In contrast, no clear association was observed with evening BP variability.
A previous small-scale study (n = 223) in patients with minor stroke reported a similar inverse association between orthostatic BP change and CV of home SBP. 23 Although measurement of BP and calculation of its variability in the former study was somewhat different from our study, reproducibility in independent populations strongly supports the intercorrelations as more than a population-specific phenomenon. Other findings in the previous study were a lack of association between orthostatic BP change and measureto-measure BP variability for ambulatory monitored BPs and beat-to-beat BP variability, derived from 5 minutes monitoring while supine. The current study did not measure these BPs; however, this issue deserves investigation in independent populations to further clarify intercorrelations among the BP variability indices.
Carotid hypertrophy, a representative phenotype of large artery atherosclerosis, has been reported to be a cause of orthostatic hypotension. Because baroreceptors are in aortic arches and sense BP by responding to the stretching of the arterial wall, 24 atherosclerotic changes in vasculature are thought to be a primary cause of baroreceptor dysfunction and consequent postural BP drop. 25, 26 We previously found a U-shaped association between carotid IMT and orthostatic BP change, 17 and the findings were replicated in the present analysis. Furthermore, carotid IMT was independently associated with morning and evening BP variability, suggesting large artery atherosclerosis as a common risk factor for the orthostatic BP change and day-to-day BP variability. Given the significant association of carotid atherosclerosis with more shot-(measure-to-measure) 20, 21 and long-term (visitto-visit) 27 BP variabilities, as well as the positive relationship between visit-to-visit BP variability and progression of carotid arterial remodeling, 28, 29 greater BP variability might be a cause of atherosclerotic changes in large artery and vise versa.
Given a previously reported positive association of plasma N-terminal pro-B-type natriuretic peptide levels with dayto-day and visit-to-visit BP variability, 14, 15 circulating BNP levels were considered as another possible factor affecting orthostatic and day-to-day BP variability. However, regression analyses failed to identify BNP as an independent determinant for BP variability; thus, the results did not support Values are mean ± SD or frequency. Alcohol consumption was calculated by multiplying the amount consumed in a single day and number of drinking days per week, and it was represented using Japanese traditional units of alcohol (Go), where 1 Go corresponded to 22 g of ethanol. Cardiovascular disease included symptomatic myocardial infarction and stroke. Orthostatic changes in SBP were calculated as a maximum difference between seated SBP and standing SBP measured at 1 or 3 minutes after postural change. Hypertension was defined as any or all of SBP ≥140 mm Hg, DBP ≥90 mm Hg, or taking antihypertensive drugs. Hyperglycemia was defined as any of HbA1c ≥6.5%, fasting plasma glucose ≥126 mg/dl, occasional plasma glucose ≥200 mg/dl, or taking antihyperglycemic drugs. Hyperlipidemia was defined as any or all of low-density lipoprotein cholesterol ≥140 mg/dl, high-density lipoprotein cholesterol <40 mg/dl, or taking antihyperlipidemic drugs. Abbreviations: ARV, average real variability; BMI, body mass index; BP, blood pressure; CV, coefficient of variation; DBP, diastolic blood pressure; HR, heart rate; IMT, intima-media thickness; SBP, systolic blood pressure.
a Data are available for 6,168 participants. Values are mean ± SD or frequency. Statistical significance was assessed by analysis of variance or chi-squared test. Analyses were performed by linear or logistic regression analysis, adjusted for age, sex, and BMI. Abbreviations: BMI, body mass index; IMT, intima-media thickness; SBP, systolic blood pressure.
a Data are available for 6,168 participants. our hypothesis. Although reasons for the conflicting results regarding the relationship between NPs and BP variability were unclear, a possibility was different types of NPs used for the analysis. BNP, but not N-terminal pro-B-type natriuretic peptide, is a biologically active peptide, whereas the half-life of N-terminal pro-B-type natriuretic peptide (1-2 hours) is longer than the half-life of BNP (20 minutes). 30 However, as these peptides were reported to have a similar prognostic significance 31 and show a strong correlation in plasma concentrations, 32 further investigation is needed to see whether NPs are a determinant for BP variability. Baseline BP was a factor strongly associated with both orthostatic BP change and home BP variability. However, given the results of the regression analyses, the association between orthostatic and day-to-day BP variability might not only be an epiphenomenon by sharing high BP as a common physiological determinant. The procedures in the current study, namely independent measurement of orthostatic BP changes (in the follow-up investigation) and home BPs (during the following 7 days), also support this consideration.
In contrast to morning BP variability, clear association was not observed between orthostatic BP change and evening BP variability. As several factors, namely older age, male sex, and alcohol drinking, were reported to more strongly influence evening BP than morning BP, 33, 34 susceptibility of evening BP to these factors might make it difficult to detect the association with orthostatic BP change. Results of our regression analysis that identified alcohol consumption as a determinant for evening but not morning SBP variability support this consideration. In addition to a well-recognized influence of alcohol on morning but not evening BP levels, alcohol intake may increase evening but not morning BP variability possibly via day-to-day variation of amount or timing of alcohol intake.
A strength of our study was the large population size with a multiday measured home BP. Although the number of home BP measurement days was somewhat shorter than in previous studies, 7,9,10 measuring morning BP twice for at least 3 days was suggested as an optimal schedule for assessment of home BP variability. 35 Another strength was having an objective measurement of sleep duration that enables the identification of BPs measured within 1 hour after awaking and before sleeping.
There were several limitations that warrant mention. First, we measured orthostatic BP at 1 and 3 minutes after standing Tables 1 and 2 . Abbreviations: ARV, average real variability; CV, coefficient of variation; RC, regression coefficient; SBP, systolic blood pressure. and did not measure it sequentially. The association with home BP variability might vary by detailed patterns of orthostatic BP change, particularly initial changes in orthostatic BP during 1 minute of standing. 36 Second, as reproducibility of orthostatic BP change has been reported to be modest, 37, 38 there might be potential misclassification in orthostatic hypotension. Third, detailed information on administered antihypertensive drugs was not available, although several types of antihypertensive drugs may influence orthostatic BP change, 39 as well as home BP variability. 33, 34 In summary, the current study was the first to report the association between orthostatic BP change and day-to-day home BP variability in a large general population. Our findings may help establish the relationship between the BP variability indices and clarify the pathophysiology of day-to-day home BP variability.
SUPPLEMENTARY DATA
Supplementary data are available at American Journal of Hypertension online.
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